In contrast, when BMDC immunization with SIINFEKL peptide was simultaneous with TBL-OVA transplant, an enhanced CD8+ T cell responses and a reduction in lymphoma growth was induced (Figure 6F–G), indicating that immunization at the time of tumor transplant can induce a CD8+ T cell response that is sufficient to affect tumor burden. This evidence concerns the gene CD8A and lymphoma.